AI-assisted citizen development can bypass governance controls. Learn the cybersecurity, validation, and data risks life sciences organizations need to manage.
Learn why third-party risk management in life sciences now requires continuous monitoring, regulatory alignment, and stronger vendor governance across cyber, quality, and operational risk.
Learn what FDA Cybersecurity Guidance means for medical device and life sciences companies, including 524B, risk-based validation, secure design, and ongoing cybersecurity readiness.
Audit-Readiness in life sciences depends on continuous compliance, traceability, and defensible processes that keep teams prepared for inspections year-round.
Learn how an AI Readiness Assessment helps life sciences organizations establish governance, validate AI systems, and scale adoption under GxP requirements and evolving FDA, EU AI Act, and ISO 42001 expectations.
